HCV Healthcare Providers Hub
Providing information and resources to healthcare providers who want to learn more about hepatitis C
New HCV Providers
This path offers essential onboarding information, including key guidelines, resources, and best practices to help you effectively manage hepatitis C in your patients
Existing HCV Providers
This path provides in-depth information, advanced treatment options, and the latest research to enhance your expertise in managing hepatitis C care
HCV Overview
HCV Landscape
An overview of changes in patients with HCV and treatments, emphasizing the role of nonspecialists in care
HCV Epidemiology
An overview of hepatitis C epidemiology and the need to simplify the treatment cascade to improve patient care
WHO: Combating HBV and HCV to Reach Elimination by 2030
Plans to increase prevention, testing, and treatment access to reduce new infections and mortality caused by HBV and HCV
Interested in learning more about the symptoms, testing, prevention of viral hepatitis, and current elimination plans?
Liver and Cirrhosis
Anatomy of the Liver
Animation and handout on the structure and function of the liver
Fibrosis and Cirrhosis of the Liver
A summary of the causes of fibrosis, how it occurs, the different stages, and what cirrhosis is
People Who Use Drugs
Overview of HCV Care in People Who Inject Drugs
Recommendations for screening and treatment of HCV infection in people who inject drugs
Awareness of HCV Within the People Who Inject Drugs Community
People who inject drugs are often unaware of available treatment options
The Impact of Cure Beyond Clinical Outcomes
Being cured from HCV may positively impact self-perceived mental health, physical well-being, and relationships with others
Discover more about the impact of hepatitis C among people who use drugs, including testing, prevention, and elimination efforts
Additional Key Populations
CDC: Men Who Have Sex With Men and Viral Hepatitis
Recommendations for men who have sex with men include vaccination and testing against viral hepatitis
CDC: Viral Hepatitis Among People Experiencing Homelessness
Homelessness impacts both physical and mental health, making it difficult to access health care
Emory Center for the Health of Incarcerated Persons
HCV prevalence is high among incarcerated individuals, highlighting the need for targeted efforts in correctional facilities
Discover more about the impact of hepatitis C among people who use drugs, including testing, prevention, and elimination efforts
HCV Screening
HCV Screening Guide
An overview of the AASLD/IDSA guidelines for the screening and diagnosis of patients with hepatitis C
Explore more about hepatitis C screening, including key methods, testing protocols, and strategies for early detection
Pretreatment Assessments
AASLD/IDSA: Simplified HCV Treatment Guidelines
Eligibility, recommended therapies, and monitoring steps for effective HCV treatment in adults new to therapy
Assessing Liver Damage Caused by HCV Infection: Common Laboratory Tests
Assessments to be conducted within 6 months prior to starting HCV treatment
Liver Damage Assessments to Identify Patients for Simplified HCV Treatment
Noninvasive techniques that can be used to assess liver damage
Identifying and Managing Patients Without Cirrhosis
The degree of hepatic fibrosis is key to determining the initial and follow-up management of patients
Identifying and Managing Patients With Cirrhosis
The differences between compensated and decompensated cirrhosis, how to measure the severity, and AASLD/IDSA guidelines
Pretreatment Assessment Guide
AASLD/IDSA guidance on HCV screening, diagnosis, treatment, and management
Expand your knowledge about HCV pretreatment assessments. Discover essential evaluations, patient considerations, and recommended practices
On-Treatment Monitoring
On-Treatment Monitoring Guide
AASLD/IDSA guidance for monitoring patients with diabetes or on anticoagulants
Specialty Pharmacy Brochure
Essential information on specialty pharmacies and how to collaborate with them effectively
Posttreatment Follow-Up
Posttreatment Follow-Up Guide
Guidance on follow-up for patients who have been treated for HCV infection, based on treatment success
HCV Reinfection Rates in People Who Inject Drugs
Information on HCV reinfection rates and risk reduction strategies for people who inject drugs
Explore additional resources on HCV management, covering on-treatment and posttreatment care, reinfection rates, risk reduction strategies for people who inject drugs, and the importance of outreach and care
